1. Home
  2. BNR vs PDSB Comparison

BNR vs PDSB Comparison

Compare BNR & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • PDSB
  • Stock Information
  • Founded
  • BNR 2014
  • PDSB 2005
  • Country
  • BNR China
  • PDSB United States
  • Employees
  • BNR N/A
  • PDSB N/A
  • Industry
  • BNR Medical Specialities
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNR Health Care
  • PDSB Health Care
  • Exchange
  • BNR Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • BNR 73.5M
  • PDSB 84.2M
  • IPO Year
  • BNR 2020
  • PDSB N/A
  • Fundamental
  • Price
  • BNR N/A
  • PDSB $1.64
  • Analyst Decision
  • BNR
  • PDSB Strong Buy
  • Analyst Count
  • BNR 0
  • PDSB 3
  • Target Price
  • BNR N/A
  • PDSB $14.00
  • AVG Volume (30 Days)
  • BNR 15.0K
  • PDSB 390.3K
  • Earning Date
  • BNR 12-31-2024
  • PDSB 11-14-2024
  • Dividend Yield
  • BNR N/A
  • PDSB N/A
  • EPS Growth
  • BNR N/A
  • PDSB N/A
  • EPS
  • BNR N/A
  • PDSB N/A
  • Revenue
  • BNR $72,832,704.00
  • PDSB N/A
  • Revenue This Year
  • BNR $52.90
  • PDSB N/A
  • Revenue Next Year
  • BNR $48.35
  • PDSB N/A
  • P/E Ratio
  • BNR N/A
  • PDSB N/A
  • Revenue Growth
  • BNR N/A
  • PDSB N/A
  • 52 Week Low
  • BNR $2.62
  • PDSB $1.53
  • 52 Week High
  • BNR $9.99
  • PDSB $6.68
  • Technical
  • Relative Strength Index (RSI)
  • BNR 57.52
  • PDSB 29.62
  • Support Level
  • BNR $5.96
  • PDSB $1.63
  • Resistance Level
  • BNR $7.14
  • PDSB $2.05
  • Average True Range (ATR)
  • BNR 0.50
  • PDSB 0.15
  • MACD
  • BNR -0.13
  • PDSB -0.01
  • Stochastic Oscillator
  • BNR 35.76
  • PDSB 3.04

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: